Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials-Reference-Cited by-同舟云学术

Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials

Published:2004-02 Issue:1 Volume:29 Page:37-45
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Poolsup N.,Suthisisang C.,Prathanturarug S.,Asawamekin A.,Chanchareon U.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2710.2003.00534.x/fullpdf

Reference20 articles.

1. Fortnightly review: Treatment of the common cold

2. Principles of Appropriate Antibiotic Use for Treatment of Nonspecific Upper Respiratory Tract Infections in Adults: Background

3. 4. WC Evans (2002 ) Trease and Evans pharmacognosy , 15th edn. China: WB Saunders, 417 .

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immobilization of biosynthesized gallium nanoparticles in Polyvinylpyrrolidone/Sodium alginate films: Potent bactericidal protection against food spoilage bacteria;International Journal of Biological Macromolecules;2024-08

2. Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway;Scientific Reports;2024-05-26

3. Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial);Phytomedicine;2023-10

4. Physiological Activities of the King of Bitters (Andrographis paniculata): A Review;Cureus;2023-08-15

5. Efficacy and safety of AP-Bio®(KalmCold®) in participants with uncomplicated upper respiratory tract viral infection (common cold) − A phase III, double-blind, parallel group, randomized placebo-controlled trial;Complementary Therapies in Medicine;2023-05